Overview
AI-powered multiomics platform for early cancer detection.
Details
Freenome’s blood-based tests use ML on cfDNA, methylation, and proteomics for CRC and other cancer screening.
Tags
liquid-biopsy, oncology, screening, multiomics, ml
Freenome
AI-powered multiomics platform for early cancer detection. Freenome's blood-based tests use ML on cfDNA, methylation, and proteomics for CRC and other cancer screening.
Visit Website
Genomics & Precision Medicine
liquid-biopsy oncology screening multiomics ml